These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1704163)

  • 21. [Evaluation of subrenal capsule assay (SRC) for clinical cancers].
    Akao S; Iwami N; Oya M; Terada H; Sasaki K; Ishikawa H; Kiumi F
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):607-13. PubMed ID: 8678520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitomycin-associated lung disease.
    Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
    Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
    [No Abstract]   [Full Text] [Related]  

  • 23. [Analysis of chemosensitivity against a human breast cancer xenograft (MX-1) with the subrenal capsule assay in BDF1 mice].
    Inoue K; Wang Y; Tada A; Ueno K; Kojima K; Ogawa M
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1644-50. PubMed ID: 4026333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An experimental study on subrenal capsule assay (SRCA)--problems for the use of immunosuppressive agents].
    Kikuchi H; Asamura M; Gamoh M; Okuno M; Wakui A; Takahashi T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2607-12. PubMed ID: 2774591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.
    Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H
    Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

  • 27. A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors.
    Levi FA; Blum JP; Lemaigre G; Bourut C; Reinberg A; Mathé G
    Cancer Res; 1984 Jun; 44(6):2660-7. PubMed ID: 6722799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of immunosuppressants on the subrenal capsule (SRC) assay as a chemosensitivity test].
    Irimajiri N; Haneda J; Yokoyama E; Shirakabe M; Matsumoto M; Kusunoki T; Utsunomiya J
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):449-55. PubMed ID: 3348631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HT-29 human colon cancer growth under the renal capsule of severe combined immunodeficient mice by an analogue of 1,25-dihydroxyvitamin D3, DD-003.
    Tanaka Y; Wu AY; Ikekawa N; Iseki K; Kawai M; Kobayashi Y
    Cancer Res; 1994 Oct; 54(19):5148-53. PubMed ID: 7923132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models.
    Schirner M; Hoffmann J; Menrad A; Schneider MR
    Clin Cancer Res; 1998 May; 4(5):1331-6. PubMed ID: 9607594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
    Fodstad O; Aamdal S; Pihl A; Boyd MR
    Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A simple method of testing the sensitivity to antineoplastic agents on human tumors in vivo].
    Lokshin A; Polianskaia NI; Mashkovtsev IuV; Dziubanov KG
    Biull Eksp Biol Med; 1991 Oct; 112(10):428-30. PubMed ID: 1804363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of the UFT sensitivity test using human urogenital cancers transplanted subcutaneously and under the subrenal capsule of nude mice].
    Murahashi I; Honda M; Mukae K; Hosoya Y; Takasaki E
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):231-5. PubMed ID: 3124766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subrenal capsule assay as a test to predict the effectiveness of chemotherapy in choriocarcinoma.
    Ogino M; Sakamoto T; Yamamoto T; Mori H; Okinaga S; Arai K
    Gynecol Oncol; 1990 Jul; 38(1):32-6. PubMed ID: 2354824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug therapy of pulmonary metastases of breast cancer].
    Voznyĭ EK; Meshcheriakova NG; Melent'eva EG; Al'tshuler IuB
    Sov Med; 1990; (5):110-4. PubMed ID: 2389192
    [No Abstract]   [Full Text] [Related]  

  • 36. Critical valuation of the subrenal capsule (SRC) assay and its use in experimental therapy.
    Arnold W; Nowak C; Naundorf H; Kunde D; Wildner GP
    Strahlenther Onkol; 1989 Jul; 165(7):532-3. PubMed ID: 2546269
    [No Abstract]   [Full Text] [Related]  

  • 37. [The cellular sensitivity of the primary tumor and its metastases in breast cancer patients to cytostatics, interferon and tumor necrosis factor].
    Vorontsova AL; Garina GB; Kudriavets IuI; Ponomarev IN; Korolev VI
    Vopr Onkol; 1989; 35(11):1315-8. PubMed ID: 2609520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Responsiveness of brain tumors to chemotherapeutic agents in the subrenal capsule assay].
    Yamada K; Itoh S; Saitoh S; Nakai O; Wechsler W
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1241-8. PubMed ID: 3729448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The subrenal capsule assay in immunocompetent mice--the inevitable role of histopathology in assessment of this method as a tool determining tumor sensitivity to cytostatic drugs.
    Marek J; Bechynĕ M
    Neoplasma; 1990; 37(1):23-30. PubMed ID: 2320176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preclinical evaluation of several cisplatinum analogs against human esophageal carcinoma by subrenal capsule assay].
    Terashima M; Ikeda K; Kawamura S; Takagane A; Maesawa C; Sudoh T; Okamoto K; Ishida K; Satoh M; Saito K
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):269-73. PubMed ID: 2405778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.